Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

DEOGEN2: prediction and interactive visualization of single amino acid variant deleteriousness in human proteins.

Raimondi D, Tanyalcin I, Ferté J, Gazzo A, Orlando G, Lenaerts T, Rooman M, Vranken W.

Nucleic Acids Res. 2017 Jul 3;45(W1):W201-W206. doi: 10.1093/nar/gkx390.

2.

Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.

Pérez-Martínez FC, Vela-Navarrete R, Virseda J, Ocaña AV, Lluel P, Rekik M, Bienaymé H, Ferté J, Attali P, Palea S.

Urol Int. 2011;86(2):210-9. doi: 10.1159/000321226. Epub 2010 Nov 13.

PMID:
21071917
3.

Characterization of two pharmacophores on the multidrug transporter P-glycoprotein.

Garrigues A, Loiseau N, Delaforge M, Ferté J, Garrigos M, André F, Orlowski S.

Mol Pharmacol. 2002 Dec;62(6):1288-98.

5.

Flavonoid-related modulators of multidrug resistance: synthesis, pharmacological activity, and structure-activity relationships.

Ferté J, Kühnel JM, Chapuis G, Rolland Y, Lewin G, Schwaller MA.

J Med Chem. 1999 Feb 11;42(3):478-89.

PMID:
9986718
6.

Projected electricity generation costs: 2005-2010.

de la Ferté J.

Health Phys. 1999 Feb;76(2):203-4. No abstract available.

PMID:
9929135
7.

NEA attacks the millennium bug. Nuclear Energy Agency.

de la Ferté J.

Health Phys. 1999 Feb;76(2):202. No abstract available.

PMID:
9929133
8.

Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.

de Verdière AC, Dubernet C, Némati F, Soma E, Appel M, Ferté J, Bernard S, Puisieux F, Couvreur P.

Br J Cancer. 1997;76(2):198-205.

9.

[Nodular primary localized cutaneous amyloidosis of the tip of the nose].

Blanc F, Triller R, Ferte JF, Itasse H, Schernberg C, Pluot M, Kalis B.

Ann Dermatol Venereol. 1985;112(9):701-2. French. No abstract available.

PMID:
4091419

Supplemental Content

Support Center